Dexamethasone and Analgesic Duration After Supraclavicular Brachial Plexus Blockade
Launched by UNIVERSITY HEALTH NETWORK, TORONTO · Dec 3, 2008
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients having unilateral hand or forearm surgery under Supraclavicular brachial plexus blockade.
- • 2. ASA I-III
- • 3. Age 18-60
- • 4. BMI \< 35
- Exclusion Criteria:
- • 1. Patients with a known history of hypersensitivity to local anesthetics and dexamethasone.
- • 2. Contra-indication to regional anesthesia/ supraclavicular brachial plexus blockade e.g. bleeding diathesis, coagulopathy.
- • 3. Peripheral neuropathy.
- • 4. Peptic ulcer disease.
- • 5. Diabetes Mellitus.
- • 6. Inability to give informed consent.
About University Health Network, Toronto
University Health Network (UHN), based in Toronto, is a leading academic health sciences center dedicated to advancing patient care through innovative research and education. As a prominent sponsor of clinical trials, UHN integrates cutting-edge scientific discoveries with clinical practice, facilitating the development of new therapies and treatment modalities. With a commitment to improving health outcomes, UHN collaborates with a diverse network of researchers, healthcare professionals, and industry partners, fostering an environment that prioritizes patient safety and ethical standards in clinical research. Through its extensive resources and expertise, UHN plays a pivotal role in transforming healthcare and enhancing the quality of life for patients both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials